Antiaging Quantum Living (AAQL) Research & Development (2023 - 2026)

Antiaging Quantum Living has reported Research & Development for 4 years, with the latest figure at $42248.0 in Q1 2026.

• Quarterly Research & Development rose 130.79% year-over-year to $42248.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $160731.0 (up 1.64% YoY) and the FY2026 annual result came in at $160731.0, up 1.64% from the prior year.
• Research & Development fell to $42248.0 in Q1 2026 per AAQL's latest filing, from $75228.0 in the prior quarter.
• Over five years, Research & Development peaked at $130933.0 in Q2 2024 and troughed at -$137202.0 in Q1 2025.
• A 4-year average of $39010.3 and a median of $51398.5 in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2024 and 2025: Research & Development surged 500.09% in 2024, then sank 326.6% in 2025.
• Over 4 years, Research & Development stood at $10687.0 in 2023, then soared by 500.09% to $64132.0 in 2024, then gained by 17.3% to $75228.0 in 2025, then slumped by 43.84% to $42248.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $42248.0, $75228.0, and $30643.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.